Participated · Series A · Aug 2026

Guoao Technology develops a proprietary ZR multi-degree-of-freedom motor that produces simultaneous linear and rotational motion and powers precision industrial embodied robots. Its product lineup includes core ZR motor components for semiconductor and 3C equipment and integrated robot solutions; key customers include a domestic leading chipmaker, GoerTek, Sunny Optical and several die-bonder and packaging/test-equipment makers. In April 2026 the company launched the G-Tools industrial embodied robot demonstrating micrometer-level positioning (±2 μm) and high-precision force control (±0.05 N). Guoao operates a manufacturing and assembly plant in Ganzhou that began mass production in mid-2025 with capacity of roughly 1,800–2,000 units per month and plans two additional factories in the Pearl River Delta and Yangtze River Delta. The team grew from about 60 employees last year to 140, and management expects nearly ¥100 million in revenue in 2026 and to reach profitability.

Participated · Series B · Jul 2026

Founded in 2021 by Jia Kui, a professor at The Chinese University of Hong Kong (Shenzhen), Cobot AI builds simulation-driven embodied intelligence powered by its DexVerse™ engine to compress R&D cycles for robot adaptation. The company implements a world-model approach (Dexterity-BEV) that aligns multi-camera and sensor observations into a unified 3D coordinate system to improve generalization across different robot embodiments. Cobot AI pursues a two-pronged commercial strategy: licensing model capabilities to third-party robotic arms for precision manufacturing tasks and deploying its DexForce W1 humanoid robots in service scenarios such as coffee, smart retail, and tourism guidance. Its products and technologies have been deployed across more than 50 niche industries, with humanoid-robot shipments reaching the hundreds-of-units level in the first half of 2026. Cobot AI reported revenue exceeding 100 million yuan in 2025 and said it expects revenue to triple year-on-year in 2026; during the May Day holiday it recorded peak single-store revenue above 100,000 yuan across more than a dozen stores.

Participated · Series B · Jun 2026

Since its founding in 2021, DexForce has focused on physical AI and world models, pursuing an integrated approach that combines world modeling, physics simulation, and real-world robot deployment. Its proprietary DexWorldModel is described as a core engine that models three-dimensional physical laws with dynamic latent-space modeling, unified coordinate alignment, and precise spatiotemporal matching. The company says this enables improved spatial perception and physical modeling to support tasks such as sorting, assembly, and dual-arm manipulation. DexForce claims to have outpaced larger peers on several technological milestones and recently topped the WorldArena benchmark for embodied world models. Financially, it generated ¥100 million in revenue in the first half of the year and is on track to surpass ¥300 million for the full year. Post-Series B, the company plans to invest in algorithm iteration, physics engine upgrades, data infrastructure, and further development and deployment of humanoid robot capabilities.

Participated · Series B · Jun 2026

HemaCell develops cell therapeutics centered on the platelet lineage, with a flagship product described as the world's first megakaryocyte injection and a pipeline of platelet injection candidates. The company aims to address blood supply shortages and reduce adverse consequences associated with blood transfusions, while pursuing platelet-derived therapeutics for aging-related indications. HemaCell is advancing multiple clinical trials for its lead program and plans to use recent Series B proceeds to support those trials and pipeline development. Management has signaled plans for a pre-IPO fundraising within the year to build manufacturing bases and expand production capacity. Founder Zhu Fangfang stated the company will continue steady, market- and clinic-driven development and rapidly pursue capital market milestones to enable eventual product launches.

Participated · Series A · Jun 2026

Tripo AI develops AI 3D foundation models, world models, and a one-stop creative workspace for producing, editing, and rendering spatial content. Its recent model releases, Tripo H3.1 and Tripo P1.0 (March 2026), focus on high-precision geometry and production-ready meshes, and Tripo Studio includes features such as native 8K AI textures and Intelligent Part Segmentation V2. The company also runs an open-source initiative (projects released in 2024, 2025, and a third season) sharing components across the AI 3D stack, including collaborations with academic partners. With the nearly $200 million raised in its Series A+ and A++ financings, Tripo plans to expand research teams, accelerate algorithms, and bolster data and infrastructure to scale its product and ecosystem globally. It introduced Project Eden as a research effort to build persistent, editable, and multiplayer world models that separate world state from rendering to enable long-horizon persistence and concurrent interactions.